Fundraising FoxFrazier Life Sciences — 2020 Investments
6 investments dated 2020 · listed companies and verified rows first · show all
Vaxcyte is a biotech company developing vaccines to treat or prevent serious infectious diseases.
BiotechDeep TechHealthtechSouth San Francisco, US
Grant Pickering(Chief Executive Officer, Director and Co-Founder)Jeff Fairman(Vice President of Research and Co-Founder)Ashish Khanna(Executive Officer)
BoardTracy Saxton(Director)William Newell(Director)Kurt von Emster(Director)in
Board seatPatrick Heron· per SEC Form D
Co-investorsAbingworthCTI Life Sciences Fund L.P.Foresite CapitalJanus Henderson InvestorsLongitude CapitalMedicxi+4 more
Erasca is a clinical-stage oncology company developing therapies targeting RAS- and MAPK pathway-driven cancers using a modality-agnostic approach including small molecules, large molecules, and protein degraders.
BiotechDeep TechDigital HealthMedical DevicesSan Diego, US
Jonathan E. Lim, M.D.(Chairman, CEO and Co-founder)Gary Yeung, CFA(Chief Business Officer)in
BoardAlexander W. Casdin(Director)Pratik S. Multani, M.D.(Director)Valerie Harding-Start(Director)James A. Bristol, Ph.D.(Director)
Co-investorsAndreessen HorowitzARCH Venture PartnersColt VenturesEvolution VC PartnersLifeSci Venture PartnersCity Hill Ventures+1 more
Iterum Therapeutics develops anti-infective compounds to treat infections caused by multi-drug resistant pathogens.
BiotechDigital HealthHealthtechMedical DevicesDublin, US
Michael W. Dunne(Executive Officer, Promoter)inCorey N. Fishman(Executive Officer, Director, Promoter)inJudith M. Matthews(Executive Officer, Promoter)Jeff Schaffnit(Executive Officer)
BoardBrenton K. Ahrens(Director)Ronald M. Hunt(Director)
Board seatPatrick J. Heron· per SEC Form D · $2.8M raise · filed Jul 2020
Co-investorsBay City CapitalCanaan PartnersSofinnova VenturesAdvent Life SciencesDolby Family VenturesSofinnova Venture Partners
Cyprium Therapeutics develops therapies for rare genetic diseases, with a focus on treatments for Menkes disease.
BiotechDigital HealthHealthtechMedical DevicesNew York, US
Lung Yam(Executive Officer)in
BoardLindsay A. Rosenwald(Director)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Imago BioSciences, Inc.Iterum Therapeutics Bermuda
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.